Skip to main content

Table 2 Multilevel logistic regressions in CHD patients (dependent variable: adherence to disease management quality indicators)

From: Prevalence of chronic diseases by immigrant status and disparities in chronic disease management in immigrants: a population-based cohort study, Valore Project

   OR 95%LL 95%UL p
Therapy with ACE inhibitors      
Nationality (Italian = reference) HDC 0.73 0.55 0.97 0.03
  HMPC 0.58 0.50 0.67 0.00
Therapy with anti-thrombotic agents      
Nationality (Italian = reference) HDC 1.02 0.76 1.39 0.86
  HMPC 0.59 0.50 0.68 0.00
Annual total cholesterol monitoring      
Nationality (Italian = reference) HDC 0.84 0.63 1.12 0.23
  HMPC 0.47 0.40 0.54 0.00
  1. All regressions adjusted for gender, age band (16–44, 45–64, 65–74, 75–84, > 85 years), time since diagnosis (dichotomized as ≤3y and >3y), and the Charlson index on a first level, and health districts on a second level.